Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models.

Abraham CG, Kulesza CA.

J Virol. 2013 Dec;87(24):13193-205. doi: 10.1128/JVI.02420-13. Epub 2013 Sep 25.

2.
4.

Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases.

Gan X, Wang H, Yu Y, Yi W, Zhu S, Li E, Liang Y.

PLoS One. 2017 Apr 13;12(4):e0175390. doi: 10.1371/journal.pone.0175390. eCollection 2017.

5.

Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication.

Hwang J, Saffert RT, Kalejta RF.

MBio. 2011 Mar 29;2(2):e00023-11. doi: 10.1128/mBio.00023-11. Print 2011.

6.

Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.

Rossetto CC, Tarrant-Elorza M, Pari GS.

PLoS Pathog. 2013;9(5):e1003366. doi: 10.1371/journal.ppat.1003366. Epub 2013 May 23.

7.

Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection.

Sinclair J.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):286-95. doi: 10.1016/j.bbagrm.2009.08.001. Epub 2009 Aug 12. Review.

PMID:
19682613
8.

Chromatin-mediated regulation of cytomegalovirus gene expression.

Reeves MB.

Virus Res. 2011 May;157(2):134-43. doi: 10.1016/j.virusres.2010.09.019. Epub 2010 Sep 25. Review.

9.

The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.

Sourvinos G, Morou A, Sanidas I, Codruta I, Ezell SA, Doxaki C, Kampranis SC, Kottakis F, Tsichlis PN.

PLoS Pathog. 2014 May 15;10(5):e1004136. doi: 10.1371/journal.ppat.1004136. eCollection 2014 May.

10.

Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency.

Qin Q, Penkert RR, Kalejta RF.

J Virol. 2013 Sep;87(17):9886-94. doi: 10.1128/JVI.01726-13. Epub 2013 Jul 3.

11.

Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.

Shen ZZ, Pan X, Miao LF, Ye HQ, Chavanas S, Davrinche C, McVoy M, Luo MH.

PLoS One. 2014 Feb 12;9(2):e88531. doi: 10.1371/journal.pone.0088531. eCollection 2014.

12.

An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.

Li G, Rak M, Nguyen CC, Umashankar M, Goodrum FD, Kamil JP.

J Virol. 2014 Jun;88(11):6047-60. doi: 10.1128/JVI.00447-14. Epub 2014 Mar 12.

13.
14.

Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.

Cliffe AR, Garber DA, Knipe DM.

J Virol. 2009 Aug;83(16):8182-90. doi: 10.1128/JVI.00712-09. Epub 2009 Jun 10.

15.

Nascent RNA interaction keeps PRC2 activity poised and in check.

Kaneko S, Son J, Bonasio R, Shen SS, Reinberg D.

Genes Dev. 2014 Sep 15;28(18):1983-8. doi: 10.1101/gad.247940.114. Epub 2014 Aug 28.

16.

Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Savaryn JP, Reitsma JM, Bigley TM, Halligan BD, Qian Z, Yu D, Terhune SS.

J Virol. 2013 Mar;87(5):2463-74. doi: 10.1128/JVI.01926-12. Epub 2012 Dec 12.

17.

Human cytomegalovirus manipulation of latently infected cells.

Sinclair JH, Reeves MB.

Viruses. 2013 Nov 21;5(11):2803-24. doi: 10.3390/v5112803. Review.

18.

Polycomb repressive complex 2 targets murine cytomegalovirus chromatin for modification and associates with viral replication centers.

Abraham CG, Kulesza CA.

PLoS One. 2012;7(1):e29410. doi: 10.1371/journal.pone.0029410. Epub 2012 Jan 18.

19.

Differential role for host translation factors in host and viral protein synthesis during human cytomegalovirus infection.

Lenarcic EM, Ziehr B, De Leon G, Mitchell D, Moorman NJ.

J Virol. 2014 Feb;88(3):1473-83. doi: 10.1128/JVI.02321-13. Epub 2013 Nov 6.

20.

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J.

Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Review.

Supplemental Content

Support Center